Peng et al., 2001 - Google Patents
Determination of peripheral blood stem cells by the Sysmex SE‐9500Peng et al., 2001
- Document ID
- 7251315594863432961
- Author
- Peng L
- Yang J
- Yang H
- Peng Z
- Xu C
- Liu T
- Publication year
- Publication venue
- Clinical & Laboratory Haematology
External Links
Snippet
The Sysmex SE‐9500 automated haematology analyser provides an estimate of immature cells, referred to as 'haematopoietic progenitor cells'(HPC). The aim of this study was to evaluate the reliability and usefulness of the SE‐9500 HPC parameter as compared with the …
- 239000011886 peripheral blood 0 title abstract description 30
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Electro-optical investigation, e.g. flow cytometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
- G01N2015/0065—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials biological, e.g. blood
- G01N2015/0069—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials biological, e.g. blood with lysing, e.g. of erythrocyts
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Fujimoto et al. | Flow cytometric method for enumeration and classification of reactive immature granulocyte populations | |
Roussel et al. | Refining the white blood cell differential: the first flow cytometry routine application | |
Sutherland et al. | Enumeration of CD 34+ Hematopoietic Stem and Progenitor Cells | |
Gratama et al. | Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells | |
Kimoto et al. | Further development of the rat Pig‐a mutation assay: Measuring rat Pig‐a mutant bone marrow erythroids and a high throughput assay for mutant peripheral blood reticulocytes | |
Pollard et al. | Use of the haemopoietic progenitor cell count of the Sysmex SE‐9500 to refine apheresis timing of peripheral blood stem cells | |
Brooimans et al. | Flow cytometric differential of leukocyte populations in normal bone marrow: Influence of peripheral blood contamination1 | |
Granger et al. | Quality assessment of CD34+ stem cell enumeration: experience of the United Kingdom National External Quality Assessment Scheme (UK NEQAS) using a unique stable whole blood preparation | |
Komada et al. | Flow cytometric analysis of peripheral blood and bone marrow for tumor cells in patients with neuroblastoma | |
Upham et al. | Simplified quantitation of myeloid dendritic cells in peripheral blood using flow cytometry | |
Dima et al. | Assessment of haematopoietic progenitor cell counting with the Sysmex® XN-1000 to guide timing of apheresis of peripheral blood stem cells | |
Linssen et al. | Identification and quantification of high fluorescence‐stained lymphocytes as antibody synthesizing/secreting cells using the automated routine hematology analyzer XE‐2100 | |
Alhan et al. | Application of flow cytometry for myelodysplastic syndromes: Pitfalls and technical considerations | |
Groeneveld et al. | Immunophenotyping of posttraumatic neutrophils on a routine haematology analyser | |
Furundarena et al. | Evaluation of the predictive value of the hematopoietic progenitor cell count using an automated hematology analyzer for CD34+ stem cell mobilization and apheresis product yield | |
Bayly et al. | Validation of a modified pre‐lysis sample preparation technique for flow cytometric minimal residual disease assessment in multiple myeloma, chronic lymphocytic leukemia, and B‐non Hodgkin lymphoma | |
Peng et al. | Determination of peripheral blood stem cells by the Sysmex SE‐9500 | |
Tanosaki et al. | Novel and rapid enumeration method of peripheral blood stem cells using automated hematology analyzer | |
Grimaldi et al. | Evaluation of the monocyte counting by two automated haematology analysers compared with flow cytometry | |
Plank et al. | The effect of erythrocyte lysing reagents on enumeration of leukocyte subpopulations compared with a no‐lyse‐no‐wash protocol | |
Peghini et al. | Clinical evaluation of an aerolysin‐based screening test for paroxysmal nocturnal haemoglobinuria | |
Xiang et al. | Evaluation of mindray bc‐5000 hematology analyzer: a new miniature 5‐part wbc differential instrument | |
Wang et al. | Development and clinical application of nucleated red blood cell counting and staging on the automated haematology analyser XE‐2100TM | |
Toft‐Petersen et al. | The CLEC12A receptor marks human basophils: Potential implications for minimal residual disease detection in acute myeloid leukemia | |
Jacob et al. | One tube with eight antibodies for 14‐part bone marrow leukocyte differential using flow cytometry |